Better Therapeutics shares surged in the extended session Monday after the company got FDA approval for its smartphone-based behavioral diabetes therapy.
MarketWatch.com - Top Stories, MarketWatch
Mon, 07/10/2023 - 5:20pm
Better Therapeutics shares surged in the extended session Monday after the company got FDA approval for its smartphone-based behavioral diabetes therapy.